EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence

Marika Quadri, Roberta Lotti, Laura Bonzano, Silvana Ciardo, Mario Bruno Guanti, Giovanni Pellacani, Carlo Pincelli, Alessandra Marconi

Skin Pharmacology and Physiology · 2021 · 34 (1) · 8-18

DOI: 10.1159/000513055 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Skin Pharmacology and Physiology, online erschienen am 18.02.2021. Verfasst von Marika Quadri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical, Medical, Dental, and Morphological Sciences, Dermolab, University of Modena and Reggio Emilia, Modena, Italy, marika.quadri@u…. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emollients capable of restoring the skin barrier function would extend their role beyond basic maintenance therapy in atopic dermatitis (AD).

Objectives

Investigate the effect of a novel emollient plus cream (EC; Dermoflan®) on the skin barrier in vitro and in patients with mild-to-moderate AD.

Methods

The effect of EC on the skin barrier recovery was evaluated using a tape-stripping (TS) model. After TS, organ cultures were treated with EC (undiluted or diluted 1:1 with water) and analyzed at 18–120 h using hematoxylin and eosin, Oil Red O, immunohistochemical, and immunofluorescent techniques. In a double-blind, randomized study, EC or placebo was applied once daily for 2 months to antecubital folds of the upper and lower limbs of patients with mild-to-moderate AD in clinical remission. Epidermal thickness, vascularization, and epidermal hydration were assessed by optical coherence tomography and corneometry, respectively, at baseline, and 1 and 2 months following treatment initiation.

Results

Following TS, EC treatment significantly increased epidermal thickness and lipid content versus diluent in the skin organ culture, as well as claudin-1, involucrin, and caspase-14 expression, suggesting skin barrier repair. EC treatment also decreased keratin-16 expression and increased levels of Toll-like receptors 1 and 2 versus diluent, suggesting involvement in regulating the epidermal immune response. In 20 patients randomized 1:1 to EC or placebo, EC treatment at the elbow fold/popliteal fossa significantly decreased epidermal thickness after 2 months, and the number of blood vessels at the elbow fold after 1 and 2 months, versus placebo. EC significantly improved the skin hydration after 2 months versus baseline.

Conclusions

This novel multi-action EC may help to restore epidermal homeostasis and improve the skin of patients with AD. Results indicate that this novel multi-action EC could be a valid adjuvant therapy in patients with AD. Key Message: Novel multi-action emollient cream helps to restore epidermal homeostasis and improves the skin affected by AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, CutaneousAdultDermatitis, AtopicDouble-Blind MethodEmollientsEpidermisFemaleHumansLipidsMaleMiddle AgedSeverity of Illness IndexSkinSkin CreamTomography, Optical CoherenceWater Loss, Insensible

Stichwörter der Autor:innen

Atopic dermatitisOrgan cultureSkin barrierSkin physiology/structureStratum corneum

Substanzen

EmollientsLipids

Autor:innen und Institutionen

  • Department of Surgical, Medical, Dental, and Morphological Sciences, Dermolab, University of Modena and Reggio Emilia, Modena, Italy, marika.quadri@unimore.it.
  • Department of Surgical, Medical, Dental, and Morphological Sciences, Dermolab, University of Modena and Reggio Emilia, Modena, Italy.
  • Department of Surgical, Medical, Dental, and Morphological Sciences, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.

Zitieren

APA

Quadri, M., Lotti, R., Bonzano, L., Ciardo, S., Guanti, M. B., Pellacani, G., Pincelli, C., & Marconi, A. (2021). A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence. Skin Pharmacology and Physiology, 34(1), 8-18. https://doi.org/10.1159/000513055

Vancouver

Quadri M, Lotti R, Bonzano L, Ciardo S, Guanti MB, Pellacani G, et al. A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence. Skin Pharmacology and Physiology. 2021;34(1):8-18. doi:10.1159/000513055

BibTeX
@article{Quadri2021,
  author = {Quadri, Marika and Lotti, Roberta and Bonzano, Laura and Ciardo, Silvana and Guanti, Mario Bruno and Pellacani, Giovanni and Pincelli, Carlo and Marconi, Alessandra},
  title = {A Novel Multi-Action Emollient Plus Cream Improves Skin Barrier Function in Patients with Atopic Dermatitis: In vitro and Clinical Evidence},
  journal = {Skin Pharmacology and Physiology},
  year = {2021},
  volume = {34},
  number = {1},
  pages = {8--18},
  doi = {10.1159/000513055}
}
Kostenlos starten →